assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_003071325.1_ASM307132v1	NZ_CP028956	Morganella morganii strain AR_0133 chromosome, complete genome	1	818401-818490	1	CRISPRCasFinder	no		DinG,DEDDh,cas3,TnsE_C,WYL,csa3,cas8f,cas5f,cas7f,cas6f	Orphan	CCGTGACAGGTCGGACACGCCTGC	24	0	0	NA	NA	NA	1	1	Orphan	DinG,DEDDh,cas3,TnsE_C,WYL,csa3,cas8f,cas5f,cas7f,cas6f	NA|200aa|up_0|NZ_CP028956.1_817100_817700_-,NA|29aa|down_8|NZ_CP028956.1_830391_830478_-	NA|317aa|up_9|NZ_CP028956.1_807281_808232_-	PRK01045, ispH, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase; Reviewed	NA|144aa|up_8|NZ_CP028956.1_808344_808776_-	PRK15095, PRK15095, FKBP-type peptidyl-prolyl cis-trans isomerase; Provisional	NA|174aa|up_7|NZ_CP028956.1_808836_809358_-	PRK00376, lspA, lipoprotein signal peptidase	NA|938aa|up_6|NZ_CP028956.1_809361_812175_-	PRK05743, ileS, isoleucyl-tRNA synthetase; Reviewed	NA|315aa|up_5|NZ_CP028956.1_812202_813147_-	PRK05627, PRK05627, bifunctional riboflavin kinase/FAD synthetase	NA|87aa|up_4|NZ_CP028956.1_813487_813748_+	PRK00239, rpsT, 30S ribosomal protein S20; Reviewed	NA|310aa|up_3|NZ_CP028956.1_813809_814739_-	PRK11062, nhaR, transcriptional activator NhaR; Provisional	NA|393aa|up_2|NZ_CP028956.1_814830_816009_-	PRK09561, nhaA, sodium/proton antiporter NhaA	NA|281aa|up_1|NZ_CP028956.1_816261_817104_+	TIGR03340, phn_DUF6, phosphonate utilization associated putative membrane protein	NA|200aa|up_0|NZ_CP028956.1_817100_817700_-	NA	NA|641aa|down_0|NZ_CP028956.1_819080_821003_-	PRK00290, dnaK, molecular chaperone DnaK; Provisional	NA|433aa|down_1|NZ_CP028956.1_821316_822615_-	cd17369, MFS_ShiA_like, Shikimate transporter and similar proteins of the Major Facilitator Superfamily	NA|195aa|down_2|NZ_CP028956.1_822736_823321_-	PRK09417, mogA, molybdenum cofactor biosynthesis protein MogA; Provisional	NA|318aa|down_3|NZ_CP028956.1_823427_824381_-	PRK05269, PRK05269, transaldolase B; Provisional	NA|264aa|down_4|NZ_CP028956.1_824703_825495_+	PRK02101, PRK02101, peroxide stress protein YaaA	NA|431aa|down_5|NZ_CP028956.1_825608_826901_-	PRK09225, PRK09225, threonine synthase; Validated	NA|311aa|down_6|NZ_CP028956.1_826910_827843_-	PRK01212, PRK01212, homoserine kinase; Provisional	NA|820aa|down_7|NZ_CP028956.1_827846_830306_-	PRK09436, thrA, bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional	NA|29aa|down_8|NZ_CP028956.1_830391_830478_-	NA	NA|239aa|down_9|NZ_CP028956.1_831093_831810_+	PRK11173, PRK11173, two-component response regulator; Provisional
